# Fosrenol

NDC: 54092-257
Generic name: lanthanum carbonate
Labeler / Manufacturer: Takeda Pharmaceuticals America, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: POWDER
Routes: ORAL
Marketing started: 20140924

FDA application: NDA204734

## Active ingredients

- LANTHANUM CARBONATE: 1000 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"54092-257"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=54092-257
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f10776b2-2c25-4343-aabe-68f302e5cb54